Expanding The Knowledge Tree: Big Pharma & Academia Pairings On The Rise
Executive Summary
As Big Pharma companies seek partnerships with academia to drive innovation and replenish drying pipelines, more are warming to the idea that the rewards need to be shared to keep collaborations intact long enough to see results
You may also be interested in...
Pharma and Academia: Finding New Ways to Join Hands for Mutual Benefit
As Big Pharmas seek to hedge their development risk and look for more externally sourced programs, partnerships with academic institutions are one of the many ingredients in the R&D secret sauce. Such deals aren't the academic-industry tie-ups of yore-where Big Pharma sought small money partnerships without giving a lot back to their academic partners. Business development execs view them as yet another way to access critically important innovation.
Deals Of The Week: UCB/Wilex, J&J/Vanderbilt, Alnylam/Cubist ...
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011